Assistant
- Conference
- Boston, MA
AI Drug Discovery and Development Summit 2026
Bringing Operational AI to the AI Drug Discovery & Development Summit
AI is reshaping drug discovery and development, but much of its potential remains trapped in isolated pilots.
Life sciences organizations are entering a new phase of AI adoption where success depends not just on powerful models, but on trusted knowledge, connected systems, and the ability to scale AI into mission-critical R&D workflows.
That trust starts with connecting fragmented scientific knowledge across systems, teams, and experts, giving researchers and AI agents the context they need to make informed decisions and take action.
The work that matters needs AI that is grounded, governed, and keeps your data and intelligence under your control. That’s Operational AI.
Visit us at Booth 6 to explore how leading pharmaceutical and biotech companies are moving beyond AI pilots to operational impact.
Speaking session
Operational AI for Mission-Critical R&D: The Trusted Foundation to Move Beyond the Pilot
Wednesday, October 28 | 12:00 PM – 12:30 PM | Data Management Stage
Pharmaceutical and biotech companies are investing heavily in AI, yet many initiatives struggle to move beyond isolated pilots. In this session, we’ll explore how organizations can build a trusted data foundation that connects enterprise knowledge, scientific systems, and intelligent agents to enable grounded answers, governed actions, and regulatory-compliant AI across drug discovery, clinical development, pharmacovigilance, and manufacturing.
What We’ll Showcase at Booth 6
- The Right Answers, Grounded in Scientific Knowledge: Connect knowledge across ELN, LIMS, clinical, regulatory, and other R&D systems so researchers get accurate, relevant answers that are fully traceable to their sources.
- Every Researcher, Equipped with the Deepest Knowledge: Bring scientific expertise, technical data, and prior findings together to give researchers and AI agents the context to discover, decide, and act.
- Trusted AI for Regulated and High-Stakes Environments: Grounded answers, permissioned actions, and auditable workflows designed to support GxP requirements, while keeping your data, models, and intelligence under your control.
What is the AI Drug Discovery & Development Summit 2026?
The AI Drug Discovery & Development Summit 2026 brings together pharmaceutical, biotech, R&D, and technology leaders to explore how AI can accelerate scientific discovery, improve development processes, and drive innovation across the drug development lifecycle.
As a sponsor, Sinequa by ChapsVision will showcase how Operational AI connects scientific knowledge, enterprise systems, and intelligent agents to build a trusted foundation for mission-critical R&D.
Who Should Attend
- Pharmaceutical & Biotech R&D Leaders — Research executives and scientific leaders focused on accelerating discovery, improving decision-making, and driving innovation.
- Drug Discovery & Clinical Development Professionals — Scientists and development teams looking to connect scientific knowledge and streamline complex R&D workflows.
- AI & Data Leaders — Teams responsible for scaling enterprise AI, managing scientific data, and driving digital transformation across life sciences.
- IT & Scientific Informatics Professionals — Technology leaders and architects working to connect ELN, LIMS, clinical, regulatory, and other scientific systems.
- Regulatory, Quality & Compliance Leaders — Professionals focused on data integrity, traceability, GxP compliance, and deploying AI responsibly in regulated environments.
Still need a ticket for the AI Drug Discovery & Development Summit?
As a conference sponsor, we’re able to offer complimentary registration to qualified end-user attendees and prospective customers. Complete the Book a Meeting form and we’ll follow up with registration details.
Share
